Composition
- Active ingredients
- FLUOXETINE HYDROCHLORIDE EQ 50MG BASE; OLANZAPINE EQ 12MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- FLUOXETINE HYDROCHLORIDE EQ 25MG BASE; OLANZAPINE EQ 12MG BASE · CapsuleNDA021520-004 · Discontinued
- FLUOXETINE HYDROCHLORIDE EQ 25MG BASE; OLANZAPINE EQ 6MG BASE · CapsuleNDA021520-002 · Discontinued
- FLUOXETINE HYDROCHLORIDE EQ 50MG BASE; OLANZAPINE EQ 12MG BASE · CapsuleThis page
- FLUOXETINE HYDROCHLORIDE EQ 50MG BASE; OLANZAPINE EQ 6MG BASE · CapsuleNDA021520-003 · Discontinued
- FLUOXETINE HYDROCHLORIDE EQ 25MG BASE; OLANZAPINE EQ 3MG BASE · CapsuleNDA021520-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021520.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Symbyax
- Active substance
- fluoxetine hydrochloride
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Lilly
- Status
- Discontinued
- FDA approval
- 24 Dec 2003
- Application
- NDA021520-005